Skip to main content
. Author manuscript; available in PMC: 2016 May 7.
Published in final edited form as: Leuk Res. 2013 Nov 5;38(4):430–434. doi: 10.1016/j.leukres.2013.10.026

Table 2.

Gefitinib Related Adverse Events.

TOXICITY TYPE GRADE(#)
1 2 3 4 Total
Hemoglobin 0 3 0 0 3
Neutrophils 0 0 1 3 4
Platelets 2 0 0 1 3
Fatigue 4 0 0 0 4
Weight loss 1 0 0 0 1
Dry skin 1 0 0 0 1
Rash/desquamation 0 4 0 0 4
Anorexia 1 1 0 0 2
Constipation 1 0 0 0 1
Diarrhea w/o prior colostomy 6 2 4 0 12
Muco/stomatitis (symptom) oral cavity 1 0 0 0 1
Nausea 3 0 1 0 4
Vomiting 2 0 1 0 3
GI-other 1 0 0 0 1
Infection Gr0-2 neut, skin 0 1 0 0 1
Hypoalbuminemia 0 1 0 0 1
Alkaline phosphatase 2 0 0 0 2
ALT, SGPT 1 1 1 0 3
AST, SGOT 5 0 0 0 5
Bicarbonate 0 1 0 0 1
Bilirubin 1 1 0 0 2
Hypocalcemia 2 0 0 0 2
Creatinine 1 0 0 0 1
Hyperglycemia 3 0 0 0 3
Hypomagnesemia 1 0 0 0 1
Hypokalemia 1 0 1 0 2
Hyperuricemia 2 0 0 0 2
Dizziness 2 0 0 0 2
Tearing 0 1 0 0 1
Oral cavity, pain 0 1 0 0 1
Cough 1 0 0 0 1